查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1626338

歐洲藥品包裝：市場佔有率分析、產業趨勢、統計與成長預測（2025-2030）

Europe Pharmaceutical Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

歐洲藥品包裝市場預計在預測期內年複合成長率為 7.3%

歐洲醫藥包裝-市場-IMG1

預計 2021 年至 2026 年預測期內，歐洲藥品包裝市場的年複合成長率約為 7.3%。由於生活方式的改變、越來越多的人被診斷出患有各種疾病以及政府醫療保健支出的增加，歐洲製藥業正在經歷快速成長和持續顛覆。然而，他們仍面臨藥品供應全球化、慢性生活方式增加以及假藥威脅不斷演變等挑戰。

該地區的藥品包裝行業正在應對不斷發展的製藥行業在整個市場中感受到的挑戰所帶來的影響，這些挑戰來自物理損壞、劣化和生物污染造成的各種性質的變化，它們在其中發揮著關鍵作用。

近年來，透過物聯網、基因組學和其他連網型醫療設備等平台的發展，隨著中小型企業進入市場的增加，定製藥品的本地生產以及大麻等，該地區的包裝行業出現了個性化方法的熱潮。

此外，吹灌封技術等創新技術的引入以及對防偽技術日益成長的需求正在顯著改變市場。全球化程度的提高導致製造工廠在世界各地建立，改善了原料的使用並延長了供應鏈。

此外，最近要求藥品序列化的歐盟 (EU) 法規已被添加到美國藥品供應鏈安全法案中，將合規性延長至2023 年，使序列化和追蹤舉措成為可能，以促進藥品的可追溯性和真實性。同樣，歐盟的其他法規目前要求醫療包裝上有2D碼，以驗證產品標識及其真實性，並且透過利用智慧型手機技術，數位化

根據聯合國進行的一項研究，抗體釋放到環境中會加速抗藥性菌株的出現並影響抗生素污染。針對這些案例，藥品包裝製造商更加重視永續性，考慮可回收和生物分解的包裝材料、減少碳足跡和生命週期分析。

歐洲佔全球市場的三分之一以上，僅次於北美，但包括中國在內的亞太國家的崛起正在構成威脅，對更快生產和提高保存期限的需求正在增加，我們正在引領市場。該市場的擔憂包括歐洲政府對藥品包裝的嚴格規定、與塑膠使用相關的環境問題以及所用原料成本的上升。

在 COVID-19 大流行之前，成長是由電子商務行業的成長、對永續材料的興趣增加以及智慧技術的整合所推動的。儘管如此，疫情後對泵浦、軟性泡殼鋁箔等醫療保健包裝的需求仍然激增。此外，由於對生技藥品和疫苗的需求，公司現在正在投資無菌形式並擴大生產能力。

歐洲藥品包裝市場趨勢

永續包裝材料推動市場成長

  • 眾所周知，製藥業是全球的重要污染物，因為它排放的溫室氣體比汽車排放多 55%。
  • 此外，歐洲藥品包裝公司在分配系統方面的大部分研發工作都集中在永續性、提高合規性和兒童安全考量等因素。
  • 例如，Ramaco Siebler 和 Huhtamaki 等領先公司已宣布計劃推出可靠、可回收的單位劑量包裝，用於由可回收材料（如聚烯層壓板）製成的藥品。包裝零件90%由聚丙烯或聚乙烯製成，70%以上的產品將回收。多年來，企業也大幅減少了排放。
  • 此外，2020年2月，總部位於歐洲的Natupharma A/S開發了一種新的完全生物分解性塑膠包裝解決方案，由塑膠添加劑和甘蔗組成。
  • 顯然，藥品包裝預計將轉向更永續的材料，遠離該行業傳統上嚴重依賴設計和製造的塑膠。該行業也將繼續應用聚對苯二甲酸乙二醇酯（PET），因為它可以在分子水平上分解並轉化回 PET。

德國佔有很大的市場佔有率

  • 德國是歐洲製藥和包裝行業的主要貢獻者，也是Gerresheimer AG和Schott AG等知名供應商的所在地，也是該地區最大的化學品和塑膠生產國之一，預計將佔很大市場佔有率。歸因於以下因素：
  • 例如，根據CPhI Worldwide進行的一項研究，德國在歐洲製藥業中名列前茅，資料來自CPhl的年度報告以及全球350多家製藥公司的意見。這一結果也鞏固了德國作為精英製藥市場的地位。
  • 針對此類案例，該地區的知名供應商已開始在該地區進行投資，以維持其在市場中的戰略地位。例如，2020 年2 月，Schott AG 在其位於德國米爾海姆的現有工廠建造了一座新生產工廠，並宣布了擴建計劃，以滿足對靜脈治療和高粘度藥物所用的預充式無菌聚合物注射器不斷增加的需求。施工預計 2021年終完成。
  • 該工廠將滿足對高階聚合物製成的藥品包裝不斷成長的需求，預計將在不久的將來提高肖特股份公司在藥品市場的地位。此外，2020年4月，該公司宣布計劃在2025年投資10億美元擴大其藥品包裝業務。
  • 此外，製藥和醫療設備業受到嚴格監管，重點關注製造和包裝過程的安全性和永續性方面。更好、更先進的醫療保健基礎設施的發展以及製藥公司透過聯盟和夥伴關係的發展預計將推動包裝市場的成長。

歐洲藥品包裝產業概況

歐洲藥品包裝市場由 Amcor、CCL Industries、Intrapac、Rexam Plc 和 Schott AG 等公司主導，這些公司正在推動歐洲包裝行業的永續性數位化，並透過大量研發投資擴大市場。

  • 2020 年 2 月 - Amcor 宣布與醫療塑膠回收委員會建立合作夥伴關係，以提高塑膠產品的可回收性。
  • 2020 年 6 月 - Amcor 和 Espoma Organic 合作創新永續塑膠包裝並推出新型生物基聚合物包裝。 PE（聚乙烯）薄膜含有 25% 來自甘蔗的生物基材料。
  • 2021 年 11 月 - Gerreshmeir 和 Midas Pharma 宣佈在創新自動注射器方面開展合作。隨著公司越來越注重專有智慧財產權產品，藥筒自動注射器增強了公司廣泛的設備和初級藥物包裝產品組合。

其他好處：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月分析師支持

目錄

第1章簡介

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場促進因素
    • 新興國家製藥業的成長
    • 藥物輸送裝置和泡殼包裝市場的需求不斷成長
    • 奈米技術對歐洲藥品包裝發展的貢獻
    • 非處方藥市場的成長
    • 對永續包裝材料和智慧技術整合產生興趣
  • 市場限制因素
    • 包裝成本增加
    • 更嚴格的健康監管合規標準、環境問題
  • 價值鏈/供應鏈分析
  • 波特五力分析
    • 新進入者的威脅
    • 買方議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間敵對關係的強度

第5章市場區隔

  • 依材料類型
    • 塑膠
    • 玻璃
    • 其他材料（紙/紙板、金屬）
  • 依產品類型
    • 瓶子
    • 管瓶/安瓿
    • 小袋
    • 注射器
    • 藥物管
    • 蓋子和塞子
    • 標籤
    • 其他產品類型
  • 按國家/地區
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲國家

第6章 競爭狀況

  • 公司簡介
    • Gerresheimer AG
    • CCL Industries Inc.
    • 亞太集團
    • Schott AG
    • Nipro Corporation
    • Vetter Pharma Packaging
    • Ardagh Group SA
    • Origin Pharma Packaging
    • Gaplast GmbH
    • Aptargroup Inc.
    • Nolato AB
    • APG Europe
    • SGD Pharma
    • Piramal Glass Ltd
    • Amcor Ltd.

第7章 投資分析

第8章市場的未來

簡介目錄
Product Code: 47828

The Europe Pharmaceutical Packaging Market is expected to register a CAGR of 7.3% during the forecast period.

Europe Pharmaceutical Packaging - Market - IMG1

The Europe Pharmaceutical Packaging Market is estimated to grow at a CAGR of about 7.3% over the forecast period 2021 to 2026. The pharmaceutical Industry industry in Europe is experiencing constant disruption as it experiences exponential growth with the changing lifestyle and more and more people being diagnosed with various diseases and increased spending on healthcare by the government bodies. However, it continues to face challenges such as globalization of drug supply, rise in chronic lifestyle, and evolving threat concerning counterfeit medicine, among others.

The pharmaceutical packaging industry in the region plays a vital role in helping the evolving pharma industry to address the impact associated with challenges being felt across the market, ensuring the protection of drugs against all sorts of alteration in the properties caused as a result of physical damage, degradation, biological contamination while driving boost in profits.

Over the period last few years, the packaging sector in the region has been experiencing a great deal of transformation with the industry-changing focus towards personalized approaches with development of platforms such as IoMT, genomics, and other connected medical devices, localized production of customized medicines added with the increase in the number of SMEs entering the market, increasing demand for cannabis-based medicinal products and diversification of the innovators.

Also, the introduction of innovative techniques like Blow-Fill-Seal technology and the increasing need for anti-counterfeiting technologies are changing the market drastically. The increasing globalization has resulted in the setting up of manufacturing plants all across the world, thereby improving the raw materials used and lengthening the supply chains.

Additionally, with the recent European Union (EU) regulations mandating pharmaceutical serialization is added with the US Drug Supply Chain Security Act, compliance extended to 2023 is driving the serialization and track-and-trace efforts, thereby are promoting pharmaceutical traceability and authenticity in the region. Similarly, other EU regulation now requires dimensional codes on the medical packaging to help identify the product and verify their authenticity; leveraging smartphone technology drives the digitalization of the packaging industry.

According to a study conducted by the UN, the release of antibodies into the environment will accelerate the emergence of resistant strains and will impact antibiotic pollution, which continues to be the topic of global discussion in 2020. Owing to such instances, the manufacturers of pharmaceutical packaging are showcasing greater emphasis on sustainability by considering recyclable and biodegradable packaging materials, reduction in their carbon footprint, and lifecycle analyses.

However, Europe has been the second, just behind North America with more than a third of the global market, but with the emergence of China and other Asia-Pacific nations remains a threat, the increasing need for faster production and enhanced shelf appeal are driving the market ahead. Some concerns to this market are the stringent regulations to pharmaceutical packaging by the governments across Europe, environmental concerns regarding the use of plastics, and the rising costs of raw materials used.

Before the global pandemic COVID-19, the industry was driving growth concerning the growth of the e-commerce industry, increased interest in sustainable materials, and integration of smart technologies. Still, later the pandemic, there has been a surge in demand for healthcare packaging such as pumps, flexible blister foils, among others. Also, with the need for biologics and vaccines, the companies are now investing in the sterile format and are expanding their production capacity.

Europe Pharmaceutical Packaging Market Trends

Sustainable packaging materials to drive the market growth

  • The pharmaceuticals industry is known to be a significant global polluter as it is responsible for generating the greenhouse gas emissions, i.e., 55% greater than that of the gas emitted by the automotive industry owing to the growing number of regulations and compliance such as the Paris agreement added with raising concern of people against the non-recyclable packaging materials is enabling the manufacturers to switch to sustainable materials.
  • Also, Most of the R&D efforts by Europe's pharma packaging companies concerning drug dispensing systems are focused on factors such as sustainability, increasing compliance, and child safety considerations, among others.
  • For instance, major players such as Ramaco Siebler, Huhtamaki announced their plans to launch a range of recyclable unit dose packaging for reliable pharmaceutical products to be made from recyclable material such as polyolefin laminate. The packaging component is expected to be made from 90% of either polypropylene or polyethylene, with more than 70% of the product would be recycled. Also, the companies have significantly reduced their emissions over the years.
  • Furthermore, In February 2020, Natupharma A/S, based in Europe, developed a novel completely recyclable, biodegradable plastic packaging solution made of plastic additive and sugarcane, which is aimed to be used in the pharmaceutical industry owing to its biodegradability nature that does not alter the product' shelf life.
  • Evidently, It is expected that pharma packaging will shift towards more sustainable materials by moving away from plastic, which the industry traditionally has been heavily dependent on for design and manufacturing. Also, the industry would continue the application of polyethylene terephthalate (PET) owing to its capability of breaking down its molecular level back into PET.

Germany to hold major market share

  • Germany is expected to hold a significant market share in the region owing to factors such as its significant contribution in the European pharmaceutical & packaging industry, the presence of a few prominent vendors in the region, including Gerresheimer AG and Schott AG, among others, and also being one of the largest producers of chemicals and plastics in the region.
  • For instance, According to the research conducted by CPhI Worldwide, Germany ranks as Europe's preeminent pharma industry as per the data drawn from CPhl Annual report and opinions from over 350 global pharma companies. Also, the results consolidate Germany as an elite pharmaceutical market.
  • Owing to such instances, the Prominent vendors in the region have started to invest in the region to maintain their strategic position in the market. For instance, In February 2020, Schott AG announced its plan for expansion by building a new production plant at its existing site in Mullheim, Germany, to meet the increasing demand for pre-fillable sterile polymer syringes are used in intravenous therapies and highly viscous medications. The construction is expected to be completed by the end of 2021.
  • The plant will help the company leverage the rising demand for pharmaceutical packaging made out of high-end polymer and is expected to enhance Schott AG's position in the pharmaceutical market in the near future. Also, In April 2020, the company further announced its plan to expand its pharmaceutical packaging business by investing USD 1 billion until the year 2025.
  • Moreover, the pharmaceutical and medical device industries are highly regulated and have been emphasizing the safety and sustainability aspects of manufacturing and packaging processes. The development of better and more advanced healthcare infrastructure, coupled with the growth of pharmaceutical companies through alliances and partnerships, is set to boost the growth of the packaging market.

Europe Pharmaceutical Packaging Industry Overview

The European Pharmaceutical Packaging Market is moderately fragmented due to the presence of players like Amcor, CCL Industries, Intrapac, Rexam Plc, and Schott AG upscaling the market with substantial R&D investments, driving towards the sustainability and digitization of the packaging industry in Europe.

  • February 2020 - Amcor announced the partnership with the Healthcare Plastics Recycling Council to improve the recyclability of plastic products.
  • June 2020- Amcor and Espoma Organic partnered together and innovated sustainable plastic packaging and even launched a new bio-based polymer packaging. The PE (Polyethylene) film contains 25% bio-based material that is derived from sugarcane.
  • November 2021 - Gerreshmeir and Midas Pharma announced a partnership for an innovative autoinjector is an important milestone to be a solution provider offering leading and innovative medical devices. With an increasing focus on its own-IP products, the company enhances the broad portfolio of devices and primary pharmaceutical packaging with this cartridge-based autoinjector.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growth in Pharmaceutical industries in Emerging economies
    • 4.2.2 Growing demand for drug delivery devices & Blister packaging market
    • 4.2.3 Contribution of Nano-technology in the growth of Europe Pharmaceutical packaging
    • 4.2.4 Growth in over-the-counter market
    • 4.2.5 Developing interest in sustainable packaging materials, and integration of smart technologies
  • 4.3 Market Restraints
    • 4.3.1 Increaing Packaging costs
    • 4.3.2 Stricter health regulatory compliance standards, Environmental concerns
  • 4.4 Value Chain / Supply Chain Analysis
  • 4.5 Porter's Five Forces Analysis
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitute Products
    • 4.5.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Material Type
    • 5.1.1 Plastic
    • 5.1.2 Glass
    • 5.1.3 Others Materials (Paper and Paperboard And Metal)
  • 5.2 By Product Type
    • 5.2.1 Bottles
    • 5.2.2 Vials and Ampoules
    • 5.2.3 Pouches
    • 5.2.4 Syringes
    • 5.2.5 Medication Tubes
    • 5.2.6 Caps and Closures
    • 5.2.7 Labels
    • 5.2.8 Others Product Types
  • 5.3 By Country
    • 5.3.1 United Kingdom
    • 5.3.2 Germany
    • 5.3.3 France
    • 5.3.4 Spain
    • 5.3.5 Italy
    • 5.3.6 Rest of Europe

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Gerresheimer AG
    • 6.1.2 CCL Industries Inc.
    • 6.1.3 Intrapac Group
    • 6.1.4 Schott AG
    • 6.1.5 Nipro Corporation
    • 6.1.6 Vetter Pharma Packaging
    • 6.1.7 Ardagh Group SA
    • 6.1.8 Origin Pharma Packaging
    • 6.1.9 Gaplast GmbH
    • 6.1.10 Aptargroup Inc.
    • 6.1.11 Nolato AB
    • 6.1.12 APG Europe
    • 6.1.13 SGD Pharma
    • 6.1.14 Piramal Glass Ltd
    • 6.1.15 Amcor Ltd.

7 Investment Analysis

8 Future of the Market